Business
Kite is developing a CAR-T, or chimeric antigen receptor T-cell therapy, which harnesses the body's immune cells to recognize and attack malignant cells.
Hi, what are you looking for?
Jewish Business News
Business
Teva Pharmaceutical Industries Ltd. today announced the launch of generic Axiron (testosterone) topical solution CIII, 30 mg/1.5 mL, in the US. Testosterone topical solution...
Business
The Israeli Pharma share is losing about 33% in two trading days and erasing a huge sum of $10 billion from its market value
Business
Teva will close 15 plants by the end of 2018 and exit from 45 countries by the end of 2017 ■ The company expects...
Business
The price for NeuroDerm, the largest ever acquisition of an Israeli pharmaceuticals company, reflects a 17% premium on the share price on July 21
Business
The CONCERTO trial of laquinimod in patients with relapsing-remitting multiple sclerosis did not meet its primary endpoint.
Business
The universal flu vaccine is designed to provide multi-season protection against most seasonal and pandemic human influenza virus strains.
Business
The medical cannabis products include rectal and vaginal suppositories, transdermal pain relief patches and treatment of pain, burns and psoriasis.
Business
Perrigo announced on Monday that it had signed a definitive agreement to divest its rights to the royalty stream from the global net...
Mergers & Acquisitions
Canadian company Kalytera Therapeutics, Inc. has acquired Israeli medical cannabis developer Talent Biotech. Talent is a privately held company evaluating the use of...